Avedro is in the news again. This time, they are announcing multi-million dollar investment financing from two outside sources to help them in their FDA approval process for LASIK Xtra. LASIK Xtra would combine current LASIK and cross-linking to create a more stable cornea. This would be great for patients that are more prone to regression, like certain prescriptions (high myopia, high astigmatism, hyperopia), young patients, or those with a history of RGP use. |
 |
|
|
|